These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nordihydroguaiaretic acid can suppress progression of experimental autoimmune encephalomyelitis. Wang L; Li L; Quan MY; Wang D; Jia Z; Li ZF; Li B; Guo L; Tan GJ IUBMB Life; 2018 May; 70(5):432-436. PubMed ID: 29637686 [TBL] [Abstract][Full Text] [Related]
3. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. Martín R; Hernández M; Córdova C; Nieto ML Br J Pharmacol; 2012 Jul; 166(5):1708-23. PubMed ID: 22260389 [TBL] [Abstract][Full Text] [Related]
4. p38MAPK/SGK1 signaling regulates macrophage polarization in experimental autoimmune encephalomyelitis. Li B; Tan TB; Wang L; Zhao XY; Tan GJ Aging (Albany NY); 2019 Feb; 11(3):898-907. PubMed ID: 30716717 [TBL] [Abstract][Full Text] [Related]
5. SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance. Li J; Jing J; Bai Y; Li Z; Xing R; Tan B; Ma X; Qiu WW; Du C; Du B; Yang F; Tang J; Siwko S; Liu M; Chen H; Luo J Mol Pharmacol; 2017 May; 91(5):464-474. PubMed ID: 28213589 [TBL] [Abstract][Full Text] [Related]
6. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of oxidative stress p38MAPK-SGK1 signaling axis in experimental autoimmune encephalomyelitis (EAE). Wang L; Li B; Quan MY; Li L; Chen Y; Tan GJ; Zhang J; Liu XP; Guo L Oncotarget; 2017 Jun; 8(26):42808-42816. PubMed ID: 28467798 [TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats. Abdin AA; Hasby EA Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383 [TBL] [Abstract][Full Text] [Related]
10. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
11. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Kleinewietfeld M; Manzel A; Titze J; Kvakan H; Yosef N; Linker RA; Muller DN; Hafler DA Nature; 2013 Apr; 496(7446):518-22. PubMed ID: 23467095 [TBL] [Abstract][Full Text] [Related]
12. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237 [TBL] [Abstract][Full Text] [Related]
13. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis. Zheng Q; Yang T; Fang L; Liu L; Liu H; Zhao H; Zhao Y; Guo H; Fan Y; Wang L BMC Complement Altern Med; 2015 Mar; 15():60. PubMed ID: 25887665 [TBL] [Abstract][Full Text] [Related]
14. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells. Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343 [TBL] [Abstract][Full Text] [Related]
15. Oral chitin treatment improved demyelination in murine autoimmune encephalomyelitis model by inhibition of inflammatory responses. Mami S; Yeganeh F; Salari AA; Anissian A; Azizi M; Hajimollahoseini M Int Immunopharmacol; 2020 Jul; 84():106536. PubMed ID: 32361654 [TBL] [Abstract][Full Text] [Related]
16. Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response. Ip FCF; Ng YP; Or TCT; Sun P; Fu G; Li JYH; Ye WC; Cheung TH; Ip NY PLoS One; 2017; 12(7):e0182069. PubMed ID: 28759648 [TBL] [Abstract][Full Text] [Related]
17. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
18. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling. Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway. Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of atorvastatin-modified dendritic cells pulsed with myelin oligodendrocyte glycoprotein autoantigen on experimental autoimmune encephalomyelitis. Chen Z; Yang D; Peng X; Lin J; Su Z; Li J; Zhang X; Weng Y Neuroreport; 2018 Mar; 29(4):317-327. PubMed ID: 29394220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]